Identification of a candidate drug for the treatment of facioscapulohumeral muscular dystrophy

Identification of a candidate drug for the treatment of facioscapulohumeral muscular dystrophy

Takahiro Yoshizawa1,2, Yoshitaka Tomiyama3, Naoko Shiba4, Tomohide Takaya5, Daigo Miyazaki6,10, Tsutomu Nakada2, Yuji Shiba2,4, Akinori Nakamura6,7, Tomoki Kosho2,8,9,11.

  1. Shinshu Niversity, Japan.
  2. Research Center for Advanced Science and Technology, Shinshu University, Japan.
  3. Department of Druc Discovery Science, School of Medicine, Shinshu University, Japan.
  4. Department of Regenerative Science and Medicine, School of Medicine, Shinshu University, Japan.
  5. Department of Agriculture, Graduate School of Science and Technology, Shinshu University, Japan.
  6. Laboratory of Neurology and Rheumatology, Department of Medicine, School of Medicine, Shinshu University, Japan.
  7. Department of Neurology, National Hospital Organization Matsumoto Medical Center, Japan.
  8. Deparment of Medical Genetics, School of Medicine, Shinshu University, Japan.
  9. Center for Medical Genetics, SHinshu University Hospital, Japan.
  10. Division of Support for Intractable Disease, Shinshu Medical Care Collaboration Center, Shinshu University Hospital, Japan.
  11. Division of Clinical Sequencing, School of Medicine, Shinshu University, Japan.

Human Genetics Asia 2023 (Tokyo, Japan), 2023/10/13 (Poster).